Transgelin Gene is Frequently Downregulated by Promoter DNA Hypermethylation in Breast Cancer

Overview

Journal Clin Epigenetics

Publisher Biomed Central

Specialty Genetics

Date 2015 Oct 1

PMID 26421063

Citations 19

Authors

Nilufer Sayar

Gurbet Karahan

Ozlen Konu

Betul Bozkurt

Onder Bozdogan

Isik G Yulug

Affiliations

Soon will be listed here.

Abstract

Background: CpG hypermethylation in gene promoters is a frequent mechanism of tumor suppressor gene silencing in various types of cancers. It usually occurs at early steps of cancer progression and can be detected easily, giving rise to development of promising biomarkers for both detection and progression of cancer, including breast cancer. 5-aza-2'-deoxycytidine (AZA) is a DNA demethylating and anti-cancer agent resulting in induction of genes suppressed via DNA hypermethylation.

Results: Using microarray expression profiling of AZA- or DMSO-treated breast cancer and non-tumorigenic breast (NTB) cells, we identified for the first time TAGLN gene as a target of DNA hypermethylation in breast cancer. TAGLN expression was significantly and frequently downregulated via promoter DNA hypermethylation in breast cancer cells compared to NTB cells, and also in 13/21 (61.9 %) of breast tumors compared to matched normal tissues. Analyses of public microarray methylation data showed that TAGLN was also hypermethylated in 63.02 % of tumors compared to normal tissues; relapse-free survival of patients was worse with higher TAGLN methylation; and methylation levels could discriminate between tumors and healthy tissues with 83.14 % sensitivity and 100 % specificity. Additionally, qRT-PCR and immunohistochemistry experiments showed that TAGLN expression was significantly downregulated in two more independent sets of breast tumors compared to normal tissues and was lower in tumors with poor prognosis. Colony formation was increased in TAGLN silenced NTB cells, while decreased in overexpressing BC cells.

Conclusions: TAGLN gene is frequently downregulated by DNA hypermethylation, and TAGLN promoter methylation profiles could serve as a future diagnostic biomarker, with possible clinical impact regarding the prognosis in breast cancer.

Citing Articles

Transgelin Promotes Glioblastoma Stem Cell Hypoxic Responses and Maintenance Through p53 Acetylation.

Li H, Song C, Zhang Y, Liu G, Mi H, Li Y Adv Sci (Weinh). 2023; 11(7):e2305620.

PMID: 38087889 PMC: 10870072. DOI: 10.1002/advs.202305620.

Single-cell sequencing analysis reveals the relationship between tumor microenvironment cells and oxidative stress in breast cancer bone metastases.

Zhang M, Chai X, Wang L, Mo K, Chen W, Xie X Aging (Albany NY). 2023; 15(14):6950-6968.

PMID: 37470685 PMC: 10415571. DOI: 10.18632/aging.204885.

Evolution and function of calponin and transgelin.

Hsieh T, Jin J Front Cell Dev Biol. 2023; 11:1206147.

PMID: 37363722 PMC: 10285543. DOI: 10.3389/fcell.2023.1206147.

Transgelin promotes ferroptosis to inhibit the malignant progression of esophageal squamous cell carcinoma.

Chen Q, Zhang L, Wan C, Yang B, Kong X, Xu X Int J Oncol. 2023; 63(1).

PMID: 37203411 PMC: 10237256. DOI: 10.3892/ijo.2023.5524.

Differentially expressed genes related to lymph node metastasis in advanced laryngeal squamous cell cancers.

Bayir O, Asik M, Saylam G, Pinarli F, Tatar E, Han U Oncol Lett. 2022; 24(5):409.

PMID: 36245825 PMC: 9555062. DOI: 10.3892/ol.2022.13529.

References

Shen J, Yang M, Ju D, Jiang H, Zheng J, Xu Z . Disruption of SM22 promotes inflammation after artery injury via nuclear factor kappaB activation. Circ Res. 2010; 106(8):1351-62. PMC: 2896867. DOI: 10.1161/CIRCRESAHA.109.213900. View

Shukla S, Mirza S, Sharma G, Parshad R, Gupta S, Ralhan R . Detection of RASSF1A and RARbeta hypermethylation in serum DNA from breast cancer patients. Epigenetics. 2007; 1(2):88-93. DOI: 10.4161/epi.1.2.2679. View

Klade C, Voss T, Krystek E, Ahorn H, Zatloukal K, Pummer K . Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics. 2001; 1(7):890-8. DOI: 10.1002/1615-9861(200107)1:7<890::AID-PROT890>3.0.CO;2-Z. View

Prinjha R, SHAPLAND C, Hsuan J, Totty N, Mason I, Lawson D . Cloning and sequencing of cDNAs encoding the actin cross-linking protein transgelin defines a new family of actin-associated proteins. Cell Motil Cytoskeleton. 1994; 28(3):243-55. DOI: 10.1002/cm.970280307. View

Hirasawa Y, Arai M, Imazeki F, Tada M, Mikata R, Fukai K . Methylation status of genes upregulated by demethylating agent 5-aza-2'-deoxycytidine in hepatocellular carcinoma. Oncology. 2007; 71(1-2):77-85. DOI: 10.1159/000100475. View

Fackler M, Umbricht C, Williams D, Argani P, Cruz L, Merino V . Genome-wide methylation analysis identifies genes specific to breast cancer hormone receptor status and risk of recurrence. Cancer Res. 2011; 71(19):6195-207. PMC: 3308629. DOI: 10.1158/0008-5472.CAN-11-1630. View

Yu H, Konigshoff M, Jayachandran A, Handley D, Seeger W, Kaminski N . Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 2008; 22(6):1778-89. DOI: 10.1096/fj.07-083857. View

Gonos E, Derventzi A, Kveiborg M, Agiostratidou G, Kassem M, Clark B . Cloning and identification of genes that associate with mammalian replicative senescence. Exp Cell Res. 1998; 240(1):66-74. DOI: 10.1006/excr.1998.3948. View

Zhang R, Zhou L, Li Q, Liu J, Yao W, Wan H . Up-regulation of two actin-associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia. Am J Respir Cell Mol Biol. 2009; 41(4):467-75. DOI: 10.1165/rcmb.2008-0333OC. View

10.

Yamamura H, Masuda H, Ikeda W, Tokuyama T, Takagi M, Shibata N . Structure and expression of the human SM22alpha gene, assignment of the gene to chromosome 11, and repression of the promoter activity by cytosine DNA methylation. J Biochem. 1997; 122(1):157-67. DOI: 10.1093/oxfordjournals.jbchem.a021722. View

11.

SHAPLAND C, Lowings P, Lawson D . Identification of new actin-associated polypeptides that are modified by viral transformation and changes in cell shape. J Cell Biol. 1988; 107(1):153-61. PMC: 2115168. DOI: 10.1083/jcb.107.1.153. View

12.

Gimona M, Kaverina I, Resch G, Vignal E, Burgstaller G . Calponin repeats regulate actin filament stability and formation of podosomes in smooth muscle cells. Mol Biol Cell. 2003; 14(6):2482-91. PMC: 194896. DOI: 10.1091/mbc.e02-11-0743. View

13.

Ye J, Coulouris G, Zaretskaya I, Cutcutache I, Rozen S, Madden T . Primer-BLAST: a tool to design target-specific primers for polymerase chain reaction. BMC Bioinformatics. 2012; 13:134. PMC: 3412702. DOI: 10.1186/1471-2105-13-134. View

14.

Yu B, Chen X, Li J, Qu Y, Su L, Peng Y . Stromal fibroblasts in the microenvironment of gastric carcinomas promote tumor metastasis via upregulating TAGLN expression. BMC Cell Biol. 2013; 14:17. PMC: 3610155. DOI: 10.1186/1471-2121-14-17. View

15.

Thweatt R, Lumpkin Jr C, Goldstein S . A novel gene encoding a smooth muscle protein is overexpressed in senescent human fibroblasts. Biochem Biophys Res Commun. 1992; 187(1):1-7. DOI: 10.1016/s0006-291x(05)81449-4. View

16.

Baylin S, Esteller M, Rountree M, Bachman K, Schuebel K, Herman J . Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum Mol Genet. 2001; 10(7):687-92. DOI: 10.1093/hmg/10.7.687. View

17.

Zhao L, Wang H, Deng Y, Wang S, Liu C, Jin H . Transgelin as a suppressor is associated with poor prognosis in colorectal carcinoma patients. Mod Pathol. 2009; 22(6):786-96. DOI: 10.1038/modpathol.2009.29. View

18.

Perou C, Sorlie T, Eisen M, van de Rijn M, Jeffrey S, Rees C . Molecular portraits of human breast tumours. Nature. 2000; 406(6797):747-52. DOI: 10.1038/35021093. View

19.

Krassenstein R, Sauter E, Dulaimi E, Battagli C, Ehya H, Klein-Szanto A . Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation. Clin Cancer Res. 2004; 10(1 Pt 1):28-32. DOI: 10.1158/1078-0432.ccr-0410-3. View

20.

Kristiansen S, Jorgensen L, Guldberg P, Soletormos G . Aberrantly methylated DNA as a biomarker in breast cancer. Int J Biol Markers. 2013; 28(2):141-50. DOI: 10.5301/jbm.5000009. View